Rentokil Initial (RTO) EBITDA (2021 - 2025)

Rentokil Initial (RTO) has 5 years of EBITDA data on file, last reported at $510.0 million in Q4 2025.

• On a quarterly basis, EBITDA fell 66.24% year-over-year to $510.0 million in Q4 2025; TTM through Dec 2025 was $3.3 billion, a 33.08% decrease from a year earlier, with the FY2025 full-year figure at $1.1 billion, down 28.88% from the prior year.
• EBITDA for Q4 2025 stood at $510.0 million, up from -$230.0 million in the prior quarter.
• Over the last five years, EBITDA for RTO reached as high as $1.5 billion in Q4 2023 and fell as low as -$230.0 million in Q3 2025.
• Historically, EBITDA has averaged $872.3 million across 5 years, with a median of $959.4 million in 2022.
• Across the five-year window, EBITDA soared 51.27% in 2023 and sank 66.24% in 2025, its largest moves.
• Year by year, EBITDA stood at $911.3 million in 2021, then gained by 10.57% to $1.0 billion in 2022, then surged by 51.27% to $1.5 billion in 2023, then decreased by 0.88% to $1.5 billion in 2024, then sank by 66.24% to $510.0 million in 2025.
• Per Business Quant data, the three most recent EBITDA figures were $510.0 million in Q4 2025, -$230.0 million in Q3 2025, and $1.5 billion in Q4 2024.